Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.0000 (2.89%) ($30.3500 - $32.0000) on Fri. Dec. 2, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 73 | Latest Price | $32.0000(2.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.075% in a week (0% probabilities). TLT(-6%) GDX(-6%) VIXM(-5%) GLD(-5%) SLV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
5 Day Moving Average | $31.72(0.88%) | 10 Day Moving Average | $31.66(1.07%) | 20 Day Moving Average | $30.29(5.65%) | To recent high | -21.8% | To recent low | 20.3% | Market Cap | $630m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |